Leukemic stem cells and measurable residual disease in AML: An emerging new outcome parameter

W. Zeijlemaker

    Research output: PhD ThesisPhD-Thesis - Research and graduation internal

    1058 Downloads (Pure)
    Original languageEnglish
    Awarding Institution
    • Vrije Universiteit Amsterdam
    • Ossenkoppele, G.J., Supervisor, -
    • Schuurhuis, G.J., Co-supervisor, -
    Award date22 Nov 2017
    Print ISBNs9789463322393
    Publication statusPublished - 2017


    • acute myeloid leukemia
    • minimal/measurable residual disease
    • leukemic stem cells

    Cite this